Author Correction: Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials

Sci Rep. 2017 Nov 24;7(1):16558. doi: 10.1038/s41598-017-16510-2.

¹ Runliang Diabetes Laboratory, Diabetes Research Center, School of Medicine, Ningbo University, 315211, Ningbo, China.
² Department of Public Health, Longsai Hospital, 315200, Ningbo, China.
³ Department of Endocrinology, Changhai Hospital, Second Military Medical University, 200433, Shanghai, China. qxinyi1220@163.com.
⁴ Runliang Diabetes Laboratory, Diabetes Research Center, School of Medicine, Ningbo University, 315211, Ningbo, China. bushizhongbu@nbu.edu.cn.

Abstract

A correction to this article has been published and is linked from the HTML version of this paper. The error has been fixed in the paper.